News und Analysen

How can Advanced Micro Devices (NASDAQ: AMD) turn AI design wins and a multi‑billion dollar GPU deal into durable revenue, despite fierce competition from competitors? Watch the video below for key

Nvidia (NASDAQ:NVDA), designs GPUs and AI hardware for gaming and data centers. The stock closed Monday at $182.65, up 2.68%. Investors focused on anticipated artificial intelligence hardware

Herriot Tabuteau, CEO of Axsome Therapeutics (NASDAQ:AXSM), exercised and immediately sold 32,410 common shares in an open-market transaction on February 2, 2026, as disclosed in the SEC Form 4

On Feb. 5, 2026, Andrew Callos, Executive Vice President and Chief Commercial Officer of Cytokinetics (NASDAQ:CYTK), exercised 15,000 options for common stock and immediately sold the resulting

A key ratio for dividend investors when looking at dividend stocks is the payout ratio. Since it tells you how large the dividend is with respect to earnings, it can be a good gauge of whether or

Many of the top companies successfully cashing in on artificial intelligence (AI) are in the technology sector. However, AI is having an impact across every industry, and plenty of companies outside

Some artificial intelligence (AI)-focused companies have delivered exceptional returns over the past few years, but some investors and analysts now believe we are in an AI bubble ready to burst.

On Feb. 13, 2026, Rice Hall James & Associates, LLC disclosed a buy of QuidelOrtho (NASDAQ:QDEL) in the fourth quarter.

An SEC filing dated Feb. 13, 2026, shows Rice Hall James & Associates, LLC

Everyone should save money for retirement, since programs such as Social Security aren't meant to replace workers' entire income and face potential cuts. Building a big nest egg for your post-work

Cathie Wood, the CEO of the investment management firm Ark Invest, is known for focusing on companies with significant innovative potential. One of her firm's picks, Intellia Therapeutics (NASDAQ:

The weight-loss market has become one of the most active therapeutic areas in the pharmaceutical industry over the past few years. And based on analyst projections, it will continue growing at a

Dividend stocks are not all the same. Some will readily decrease or suspend their payouts at the first sign of trouble, while others will continue increasing them even during market downturns or

Most investors don't associate the healthcare sector with dividends, but there are some pretty impressive dividend stocks to be had. Two that stand out today are Becton, Dickinson (NYSE: BDX) and

Investors who want to capitalize on the growing weight loss market might be tempted to turn to the current leaders in the field, Eli Lilly and Novo Nordisk. Both companies are worth serious

When it comes to acronyms, the U.S. Army's Next Generation Command and Control program got the short end of the stick.

Named "NGC2," the Army's attempt to build a new command and control system

Amarin (NASDAQ: AMRN) is a drug company that is in a particularly precarious position. This fact is highlighted by the company's recent move to restructure its operations in an effort to cut costs

If you've got $1,000 to invest, I think two stocks trading right around $200 a share look quite attractive. With that amount of money, you'd be able to buy five shares of one stock or split it up

Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD) have been among the leading providers of the specialized processors used for artificial intelligence. These graphics processing units

Nvidia (NASDAQ:NVDA), which develops GPUs and AI hardware/software solutions, closed Thursday at $183.34, up 0.16%. The stock’s modest gain follows as overnight coverage highlights bullish 2026

Considering that most companies don't even stay in business for 20 years, finding stocks worth holding onto for good isn't always easy. Thankfully, some seem to have the qualities that will enable

Oncology is the largest therapeutic area in the biopharma industry, in terms of sales. The rapid rise in recent years of drugs to treat diabetes and manage weight loss might disrupt the traditional

Shares of Evolus (NASDAQ: EOLS) climbed on Wednesday after the aesthetics specialist announced that it achieved profitability.

By the close of trading, Evolus' stock price was up over 35%.

Image

Orion Group Holdings (NYSE: ORN) stock, the maritime construction company, tumbled nearly 9% in early trading Wednesday before reversing to gain more than 4%... before reversing again and giving

Change is exciting, and it comes with risks. This is why turnaround stocks are so interesting. Right now, Teva Pharmaceutical Industries (NYSE: TEVA) is a turnaround story that may appeal to